Latest filing published 25 Mar 2024 for Akoya Biosciences, Inc., €8,846.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Frederic Pla span 2 companies, the busiest being Genomic Health Inc and Akoya Biosciences, Inc. Between 15 February 2016 and 23 March 2024, the trades on record add up to 56 filings.
On the open market, the record shows 2 purchases worth €86k and 23 sales worth €4.9M. Sales outweigh purchases by €4.8M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 16 share grants and 13 option exercises.
The newest entry dates from 25 March 2024: a share grant of €8,846, in Akoya Biosciences, Inc. The latest purchase dates back some time: it was published 1,139 days ago, on 11 September 2023. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations